Why Osmotica Pharmaceuticals plc (Nasdaq: OSMT) stock dipped in the premarket?

0
882
DNAY Stock
DNAY Stock

In the premarket session, Osmotica Pharmaceuticals plc (Nasdaq: OSMT) sank -27.41% to $ 3.93 after The U.S. Food and Drug Administration has issued a Complete Response Letter regarding Osmotica Pharmaceutical’s NDA seeking approval of the investigational agent arbaclofen extended-release tablets to treat the spasticity resulting from multiple sclerosis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

In its most recent NDA amendment, the Company failed to justify the change from the initial baseline to Day 84 in TNmAS-MAL scores between groups consisting of arbaclofen 40 mg and placebo. In its clinical review letter, the FDA proposed several changes to the product, including the requirement that the Company conducts new clinical studies to provide substantial evidence of arbaclofen’s efficacy.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here